The immune reconstitution inflammatory syndrome

Indian Journal of Dermatology

Volumn 56, Issue 5, 2011, Pages 476-479

  Bosamiya, Sanjay ^a  

^a Surat Municipal Institute of Medical Education & Research   (India)

Author keywords

Adapalene; occlusion; plantar warts; treatment

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; CORTICOSTEROID; FLUCONAZOLE; FLUCYTOSINE; GANCICLOVIR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEINASE INHIBITOR; TUBERCULOSTATIC AGENT; VALGANCICLOVIR; VIRUS RNA;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; AUTOIMMUNITY; BLOOD CELL COUNT; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CLINICAL PRACTICE; CONTINUING EDUCATION; COUGHING; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS INFECTION; CYTOMEGALOVIRUS RETINITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; GENETIC SUSCEPTIBILITY; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE SYSTEM; INFECTION; KIDNEY FUNCTION TEST; LABORATORY TEST; LIVER FUNCTION TEST; MYCOBACTERIOSIS; ONSET AGE; OPPORTUNISTIC INFECTION; PATHOGENESIS; PATIENT MONITORING; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; RISK FACTOR; SEX DIFFERENCE; SPUTUM CULTURE; TATTOO; THORAX RADIOGRAPHY; TREATMENT FAILURE; TUBERCULIN TEST; TUBERCULOSIS; VARICELLA ZOSTER VIRUS; VIRUS LOAD; VITAL SIGN; WORLD HEALTH ORGANIZATION;

EID: 81255204960     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.87114     Document Type: Article

References (19)

1. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002;81:213-27. (Pubitemid 34507208)
2. Murdoch DM, Venter WD, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): A review of common infectious manifestations and treatment options. AIDS Res Ther 2007;4:9.
3. Surjushe AU, Jindal SR, Kamath RR, Saple DG. Immune reconstitution inflammatory syndrome. Indian J Dermatol Venereol Leprol 2006;72:410-4.
4. Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nat Med 1998;4:208-14. (Pubitemid 28137376)
5. Price P, Mathiot N, Krueger R, Stone S, Keane NM, French MA. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 2001;22:279-87. (Pubitemid 32846559)
6. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004;18:1615-27. (Pubitemid 39095778)
7. French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000;1:107-15.
8. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ: Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006;42:418-27. (Pubitemid 43122323)
9. Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC, Johnson MA. Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 1998;26:1008-9. (Pubitemid 28180357)
10. Mohanty K. Immune reconstitution inflammatory syndrome after initiation of highly active anti-retroviral therapy in HIV/AIDS. Indian J Dermatol Venereol Leprol 2010;76:301-4.
11. British HIV Association (BHIVA) guidelines on TB/HIV infection. Available from: http://www.bhiva.org. [cited in 2005].
12. Race EM, Adelson-Mitty J, Kriegel GR, Barlam TF, Reimann KA, Letvin NL, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998;351:252-5. (Pubitemid 28043950)
13. Robinson MR, Reed G, Csaky KG, Polis MA, Whitcup SM. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Opthalmol 2000;130:49-56.
14. Karavellas MP, Lowder CY, Macdonald C, Avila CP Jr, Freeman WR. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: A new syndrome. Arch Ophthalmol 1998;116:169-75.
15. Martinez E, Gatell J, Moran Y, Aznar E, Buira E, Guelar A, et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 1998;27:1510-3. (Pubitemid 29242429)
16. King MD, Perlino CA, Cinnamon J, Jernigan JA. Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. Int J STD AIDS 2002;13:724-6.
17. Bartlett JG, Joel EG. Medical management of HIV infection. Baltimore, Maryland USA: John Hopkins University; 2003.
18. Wislez M, Bergot E, Antoine M, Parrot A, Carette MF, Mayaud C, et al. Acute respiratory failure following HARRT introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 2001;164:847-51. (Pubitemid 32881923)
19. World Health Organization: Regional Office for South-East Asia, New Delhi. The Use of Antiretroviral therapy: A simplified approach for resource-constrained countries. July 2002.